Overexpression of Mdm2 and its clinical consequences were already described in PCa (Osman et al, 1999; Leite et al, 2001; Khor et al, 2005) but the molecular basis of this upregulation is still unclear. This evidence concerns the gene MDM2 and posterior cortical atrophy.